- Dosage: Iron Sucrose 100mg
- Volume: 5mL Ampoule / vial
- Packaging: 1 ampoule /vial in box;5 Ampoule / vial in box.
- Shelf Life: 36 months
Package:
Product Description
Product Overview
Iron Sucrose Injection 100mg/5mL is a sterile, colloidal solution of iron sucrose intended for intravenous administration. Each 5mL vial contains iron sucrose complex equivalent to 100mg of elemental iron at a concentration of 20mg/mL. Iron sucrose is a complex of polynuclear iron(III)-hydroxide stabilized by sucrose, designed for intravenous iron replacement in patients with iron deficiency who cannot tolerate or do not respond adequately to oral iron therapy, or in situations where rapid iron repletion is required. It is widely used in the management of iron deficiency anemia, particularly in patients with chronic kidney disease, inflammatory bowel disease, heavy menstrual bleeding, postpartum iron deficiency, and other conditions associated with impaired oral iron absorption or increased iron demand.
Iron Sucrose Injection 5ml:100mg Ampoule: What the Published Guidance Says
Our largest functional group by product count — from the individual vitamins and minerals carried on the WHO Model List through to parenteral nutrition components and finished multivitamin presentations.
Iron Sucrose Injection 5ml:100mg Ampoule is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Vitamins & Nutrition range overview.
- The economic case for essential medicines is documented WHO reports that medicines account for 20–60% of health spending in developing countries, with up to 90% of the population purchasing medicines through out-of-pocket payments, making medicines the largest family expenditure item after food. The 2025 Model List covers over 520 medicines, including 374 for children. WHO — Essential medicines (fact sheet)
- Anaemia prevention is a listed intervention Ferrous salt with folic acid appears on the Model List as an antianaemia medicine, in tablet form. Folic acid and iron are the standard pair used in national supplementation programmes, and matching your market's programme strength matters. WHO — Essential medicines (fact sheet)
- The Model List sections that carry this portfolio Vitamins and minerals sit in section 27 of the 24th WHO Model List (2025). The listings include ascorbic acid, cholecalciferol and ergocalciferol, iodine, nicotinamide, pyridoxine and retinol, alongside calcium and other minerals. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
These points are quoted because they shape how Iron Sucrose Injection 5ml:100mg Ampoule is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
Iron Sucrose Injection 5ml:100mg Ampoule: Specification, Pack & Documentation Summary
| Product Name | Iron Sucrose Injection |
| Specification | 100mg elemental iron per 5mL (20mg/mL) |
| Dosage Form | Sterile Colloidal Solution for Intravenous Injection / Infusion |
| Active Ingredient | Iron Sucrose (polynuclear iron(III)-hydroxide sucrose complex), equivalent to 100mg elemental iron |
| Pharmacological Class | Intravenous Iron Replacement Agent / Hematinic |
| Route of Administration | Intravenous injection (slow, undiluted) or intravenous infusion (after dilution in 0.9% Sodium Chloride Injection). NOT for intramuscular or subcutaneous injection. NOT for direct intravenous bolus injection. |
| Storage | Store below 25°C, protected from light. Do not freeze. Keep vial in outer carton until use. |
| Therapeutic group | Vitamins & Nutrition — Vitamins & Nutrition |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Alpha-Lipoic Acid Injection 5ml:125mg, L-Carnitine Injection 2ml:500mg, Pyridoxine Injection 1ml:100mg, Glutathione Injection 3000mg, Coenzyme Q10 Injection 2ml:5mg, Biotin Injection 5ml:500μg, Levocarnitine Injection 5ml:1000mg, Vitamin B1 Injection 100mg/mL.
How Iron Sucrose Injection 5ml:100mg Ampoule Is Tested and Released
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Iron Sucrose Injection 5ml:100mg Ampoule is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
Release testing on this presentation is built around:
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
How Iron Sucrose Injection 5ml:100mg Ampoule Is Packed, Labelled and Shipped
- Pack size: 5mL amber glass vial with rubber stopper and aluminum flip-off cap. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, protected from light. Do not freeze. Keep vial in outer carton until use..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Regulatory Support for Iron Sucrose Injection 5ml:100mg Ampoule
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
This page describes Iron Sucrose Injection 5ml:100mg Ampoule as a product of the vitamins, minerals and clinical nutrition products named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Questions We Are Asked About Iron Sucrose Injection 5ml:100mg Ampoule
What pack size is available for Iron Sucrose Injection 5ml:100mg Ampoule?
The reference pack is 5mL amber glass vial with rubber stopper and aluminum flip-off cap. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.
What documentation comes with a shipment of Iron Sucrose Injection 5ml:100mg Ampoule?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.
Does the batch documentation for Iron Sucrose Injection 5ml:100mg Ampoule support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
What formats do you offer for multivitamins?
Effervescent tablets, chewable tablets, lozenges, oral liquids, drops and injectables — because the appropriate dosage form differs between a paediatric programme and an adult inpatient setting.
Do you supply injectable B-complex and vitamin C?
Yes. B-complex, cyanocobalamin, thiamine, pyridoxine, ascorbic acid and combinations are supplied as injectables with assay data on the batch COA.
Companion Products — Vitamins & Nutrition
- Alpha-Lipoic Acid Injection 5ml:125mg — 5mL
- L-Carnitine Injection 2ml:500mg — 2mL
- Pyridoxine Injection 1ml:100mg — 1mL
- Glutathione Injection 3000mg — 3000mg
- Coenzyme Q10 Injection 2ml:5mg — 2mL
- Biotin Injection 5ml:500μg — 5mL
Browse the full Vitamins & Nutrition range; all Injectables; the complete product catalogue.
Request a Quotation for Iron Sucrose Injection 5ml:100mg Ampoule
Send the specification, pack size, quantity and destination market for Iron Sucrose Injection 5ml:100mg Ampoule 100mg and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
- WHO — Essential medicines (fact sheet)
- WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
